Nantahala Capital Management’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,798
| Closed | -$1.28M | – | 130 |
|
|
2024
Q4 | $1.28M | Buy |
+13,798
| New | +$1.28M | 0.06% | 103 |
|
|
2024
Q2 | – | Sell |
-2,605
| Closed | -$2.7M | – | 120 |
|
|
2024
Q1 | $2.7M | Hold |
2,605
| – | – | 0.15% | 74 |
|
|
2023
Q4 | $2.06M | Sell |
2,605
-109
| -4% | -$86.3K | 0.12% | 73 |
|
|
2023
Q3 | $1.29M | Hold |
2,714
| – | – | 0.11% | 83 |
|
|
2023
Q2 | $1.63M | Hold |
2,714
| – | – | 0.16% | 70 |
|
|
2023
Q1 | $1.92M | Buy |
2,714
+2,265
| +504% | +$1.6M | 0.15% | 66 |
|
|
2022
Q4 | $460K | Buy |
+449
| New | +$460K | 0.03% | 83 |
|